Company Filing History:
Years Active: 2010
Title: Katja Dreyer: Innovator in Pharmaceutical Chemistry
Introduction
Katja Dreyer is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. Her work has the potential to enhance the efficacy and stability of medications.
Latest Patents
Katja holds a patent for "Amorphous aripiprazole and process for the preparation thereof." This invention focuses on morphologically stabilized amorphous aripiprazole and outlines a process for preparing the same. This patent represents her commitment to advancing pharmaceutical science and improving patient outcomes.
Career Highlights
Katja is currently employed at Helm AG, where she collaborates with a team of skilled professionals. Her expertise in drug formulation and development has positioned her as a valuable asset in her field. With a patent portfolio that includes 1 patent, she continues to push the boundaries of innovation in pharmaceuticals.
Collaborations
Throughout her career, Katja has worked alongside notable colleagues such as Uwe Loeffler and Klaus Glaenzer. These collaborations have fostered a dynamic environment for research and development, leading to groundbreaking advancements in their projects.
Conclusion
Katja Dreyer exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborative efforts highlight her dedication to improving drug formulations and patient care.